July 25, 2014 11:16 PM ET

Pharmaceuticals

Company Overview of Muscagen Ltd.

Executive Profile

J. Desmond Fitzgerald FRCP

Director of Drug Development and Director, Muscagen Ltd.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background

Prof. J. Desmond Fitzgerald, FRCP, serves as Director of Drug Development of Muscagen Ltd. Dr. Fitzgerald Co-founded Biotie Therapies AG. He served as General Manager of ICIs Pharmaceuticals Division (now AstraZeneca) and also as International Medical Director of Pharmaceutical Divisional Board, where he spent 18-year career in research and development. He was involved in the discovery of several cardiovascular drugs, including the widely prescribed betablocker Tenormin. ...

Corporate Headquarters

King Edward VII Avenue
Cardiff, -- CF10 3XF

United Kingdom

Phone: --
Fax: --

Board Members Memberships

Director of Drug Development and Director

Education

Unknown/Other Education
Royal College of Surgeons in Dublin Ireland

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Muscagen Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.